MeSH term
Frequency | Condition_Probility | Humans | 48 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Azides/*pharmacology | 2 | 50.0 |
Binding Sites | 5 | 0.0 |
Cell Membrane/metabolism | 7 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Hela Cells | 9 | 0.0 |
Immunoblotting | 4 | 0.0 |
Isoxazoles/*pharmacology | 2 | 22.0 |
Leukotriene C4/metabolism | 6 | 35.0 |
Light | 2 | 0.0 |
Models, Chemical | 2 | 0.0 |
Mutation | 5 | 0.0 |
Protein Conformation | 5 | 0.0 |
Transfection | 12 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Vanadates/pharmacology | 4 | 2.0 |
Animals | 15 | 0.0 |
Female | 6 | 0.0 |
Glutathione/metabolism | 6 | 2.0 |
Male | 4 | 0.0 |
Mice | 6 | 0.0 |
ATP-Binding Cassette Transporters/*drug effects/metabolism | 2 | 100.0 |
Biological Transport | 14 | 1.0 |
Drug Resistance, Multiple | 9 | 5.0 |
*Drug Resistance, Neoplasm | 4 | 2.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
*Drug Resistance, Multiple | 2 | 1.0 |
*Membrane Transport Proteins | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
ATP-Binding Cassette Transporters/*metabolism | 3 | 3.0 |
Drug Resistance, Multiple/*physiology | 4 | 16.0 |
Multidrug Resistance-Associated Proteins | 7 | 9.0 |
Cells, Cultured | 5 | 0.0 |
P-Glycoprotein/antagonists & inhibitors/*metabolism | 2 | 25.0 |
Cell Survival/drug effects | 2 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Time Factors | 6 | 0.0 |
Adult | 4 | 0.0 |
Aged | 2 | 0.0 |
Alleles | 2 | 0.0 |
Multidrug Resistance-Associated Proteins/*genetics | 3 | 11.0 |
ATP-Binding Cassette Transporters/genetics/*metabolism | 2 | 3.0 |
Cell Line | 4 | 0.0 |
Estradiol/metabolism | 2 | 2.0 |
Kinetics | 7 | 0.0 |
Rats | 2 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Multidrug Resistance-Associated Proteins/*chemistry/physiology | 2 | 100.0 |
Photoaffinity Labels | 3 | 18.0 |
Structure-Activity Relationship | 3 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Drug Interactions | 3 | 0.0 |
Phosphorus Radioisotopes | 2 | 3.0 |
Tritium | 2 | 0.0 |
Vincristine/pharmacology | 3 | 5.0 |
HL-60 Cells | 3 | 0.0 |
Drug Resistance, Multiple/*genetics | 2 | 3.0 |
Phospholipids/*metabolism | 2 | 1.0 |
Aspartic Acid/chemistry | 2 | 6.0 |
Catalysis | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Multidrug Resistance-Associated Proteins/*chemistry/metabolism | 2 | 100.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Structure, Secondary | 5 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Microscopy, Confocal | 3 | 0.0 |
Substrate Specificity | 3 | 0.0 |
Multidrug Resistance-Associated Proteins/*chemistry/*metabolism | 2 | 100.0 |
Multidrug Resistance-Associated Proteins/genetics/*metabolism | 2 | 25.0 |
P-Glycoprotein/metabolism | 3 | 4.0 |
Species Specificity | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
Hydrolysis | 2 | 0.0 |
Multidrug Resistance-Associated Proteins/*metabolism | 3 | 20.0 |
ATP-Binding Cassette Transporters/genetics | 2 | 3.0 |
Etoposide/pharmacology | 2 | 1.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Adenosine Triphosphate/*metabolism | 2 | 2.0 |
Protein Transport | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Multidrug Resistance-Associated Proteins/*chemistry | 2 | 100.0 |
Models, Biological | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
